Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody-drug conjugate with a tubulysin analog warhead having a stabilized acetate group in the TUV subunit

Antibody-drug conjugate with a tubulysin analog warhead having a stabilized acetate group in the TUV subunit

US Patent 11020490 · Granted Jun 1, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists2025
Amorphous and crystalline forms of IDO inhibitors2025
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for t2024
Modified self-immolating moieties for use in prodrugs and conjugates and methods2024
Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods fo2023
Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods fo2023
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists a2023
Macrocyclic toll-like receptor 7 (TLR7) agonists2022
2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists a2022
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for t2022
Amorphous and crystalline forms of IDO inhibitors2022
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates there2021